ѱ ΰġŸ(VAN) ϰ ִ ü, ̽ Բ VANо 1, 2 . VAN ϰ ü Ҹ ϰ , ڽڽ忣 1998 1 ߴ. VAN̶ ī ܸ⸦ ġ ī簣 Ʈũ , ī ߰ϰų īǥ Ծ óִ ̴.
ѱ 2009 ؿ, شⰣ(2009~2015, 6) 14.4%. VAN ֿ ܸ ī ̷ Ǵ ϴ , ī Ǽ ø .
ī ̿ ų ؿԴ. 2009 2011 ü ϴٰ 3Ⱓ , ֱ , Ȩ ͳ ̿ ý ȭ ٽ ִ .
2015 ͼ . ø鼭 ȿ ǰ , 2015 7 'VAN Ծ' 1000 ̻ Ʈ پ δ. Ʈ ſī ŷ ī糪 VAN κ ǰ ܸ ̳ شѴ. Ʈ , ѱ 2015 ͷ 0.6%p 11.7% ƴ.
ٸ, ̽ ͷ Ⱓ(2014~2015) 3.5%p 12.9% Ϳ ϸ ̴. ̴ Ʈ 뿡 , 20%(-1), 30%(-3) , Ǹ 15%(+9), 14%(+16) þ δ. ȸ , Ǹ 븮 ϴ ϳ. Ȳ ϴ ü ʾҴ.
, ѱ 2008 йս ũ ߴ. ѱ 42.61% ϰ ִ ѱȭȣο йս 226 ν ִ( [VƮ 췮] ѱ, VAN).
ѱ ʾҰ, ڻ꿡 ڰ ʿ ʾ κ ڻ Ҵ. ̿ ڻ 2009 224 2015 1038 4.6谡 ߰, ü ڻ꿡 ϴ ߵ Ⱓ 23.3% 49.5% Ȯƴ. ٸ, Բ ſī ܸ ǰ Ǹؾϴ Ư ܸ شϴ ġ ڻ ̴. 2015 ġ ڻ 265̴.
ܿ 187 ڻ굵 ϰ ִµ, κ а ڻ ڻ 22, ӱڻ 130 ִ(2015 ). ʱ& ó -HBIC ûâ ó, Ư㺥ó 20% ̸̳, ӱ Ʈʽ ǰ ־ зƴ. ̱ Oncosynergy ̻ȸ ־ ڻ꿡 Եƴ.
繫µ ϴ. 1б ä 47% , 255% Ϲ 繫 ٰ Ǵϴ (ä 100% ̸, 100% ̻) ϰ ִ. ڻ Ա 6%, ں ִ ִ ǥ ں 67.
̷ , ѱ ִڻ ϸ , й սǷ ũ ߴ 2008 Ϲݱ⸦ ֱ 10Ⱓ ִڻ꺸 ݿ ŷƴ. 忡 밡 Ͱ ں ̾ οϴ Ÿ . ٸ, 2015 ʿ ִ ϰ ְ ϶ϴ .
̴ 2015 5 ī ŷ Ǵ Ḧ ŷ ݾ (2~3%) Ḧ ȯ ǰ 鼭 ѱ ѵ ̶ δ.
VAN ϴ ī ǥ() ī翡 ϴ 밡 Ǵ ᰡ ֵ Ϳ, 5 ŷ ؾ ǥ پ Ϳ ۿ . ̿ ī VAN簣 ־, ᱹ 2016 5 űȸ ī衤(VAN) '5 ī ŷ Ȯ븦 4 ȸ' ī簡 VAN翡 ǥ Ḧ δشٴ 5 īŷ ǵƴ.
ֱ ѱ Ȳ Ͽ īܸ ƴ϶ ͳ̳ Ʈ ϴ , üũϰ SKڷ CDMA ̿ ϴ ITȯ濡 ȭϰ ִ ̸, ̿ 2 5 'ī ġī óϴ ܸ ' 'Ʈ ICī ó ' Ư㵵 ´.
1б ݿ ְ(PER) 18.4, ְڻ(PBR) 3.58. ڱںͷ(ROE) 19.46%.
( 0)